TR202010752A2 - USE OF BENZIDAMINE HYDROCHLORIDE AND CHITOSAN CONTAINING MEDICAMENT IN ENDODONTIS - Google Patents

USE OF BENZIDAMINE HYDROCHLORIDE AND CHITOSAN CONTAINING MEDICAMENT IN ENDODONTIS

Info

Publication number
TR202010752A2
TR202010752A2 TR2020/10752A TR202010752A TR202010752A2 TR 202010752 A2 TR202010752 A2 TR 202010752A2 TR 2020/10752 A TR2020/10752 A TR 2020/10752A TR 202010752 A TR202010752 A TR 202010752A TR 202010752 A2 TR202010752 A2 TR 202010752A2
Authority
TR
Turkey
Prior art keywords
endodontis
containing medicament
chitosan containing
benzidamine hydrochloride
chitosan
Prior art date
Application number
TR2020/10752A
Other languages
Turkish (tr)
Inventor
Güneri̇ Peli̇n
Emi̇n Kaval Mehmet
Original Assignee
T C Ege Ueniversitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T C Ege Ueniversitesi filed Critical T C Ege Ueniversitesi
Publication of TR202010752A2 publication Critical patent/TR202010752A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş, sağlık sektöründe yer alan diş hekimliği kök kanal tedavisi uygulamalarında kullanılabilen antienflamatuar, antimikrobiyal ve analjezik özellik gösteren benzidamin hidroklorür ve kitosan içeren medikament (ilaç) ile ilgilidir.The invention relates to a medicament (drug) containing benzydamine hydrochloride and chitosan, which has anti-inflammatory, antimicrobial and analgesic properties, which can be used in dental root canal treatment applications in the health sector.

TR2020/10752A 2019-12-25 2020-07-07 USE OF BENZIDAMINE HYDROCHLORIDE AND CHITOSAN CONTAINING MEDICAMENT IN ENDODONTIS TR202010752A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201921567 2019-12-25

Publications (1)

Publication Number Publication Date
TR202010752A2 true TR202010752A2 (en) 2021-07-26

Family

ID=83366607

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2020/10752A TR202010752A2 (en) 2019-12-25 2020-07-07 USE OF BENZIDAMINE HYDROCHLORIDE AND CHITOSAN CONTAINING MEDICAMENT IN ENDODONTIS

Country Status (1)

Country Link
TR (1) TR202010752A2 (en)

Similar Documents

Publication Publication Date Title
EP4272818A3 (en) Thrombolytic agent for the treatment of thromboembolism
WO2013052958A3 (en) Antimicrobial compositions and methods employing same
BR112015027699A2 (en) USE OF ROBENIDINE OR A THERAPEUTICLY ACCEPTABLE SALT THEREOF, ANTIBACTERIAL PHARMACEUTICAL COMPOSITION AND MEDICAL DEVICE
ECSP056235A (en) ANTISEPTIC COMPOSITIONS, METHODS AND SYSTEMS
CY1112320T1 (en) TAPENDADOL TITLE
BR112015027704A2 (en) COMPOUND, USE OF THE SAME AND ANTIBACTERIAL PHARMACEUTICAL COMPOSITION
BR112017027811A2 (en) ksp inhibitor specific conjugates
CR20210376A (en) COMPOUNDS AND THEIR USE FOR THE TREATMENT OF a1-ANTITRYPSIN DEFICIENCY
CL2012003266A1 (en) Tamarind seed polysaccharide for use in the treatment of microbial infections; pharmaceutical and / or antimicrobial dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide; method to treat and / or prevent a patient who has a microbial infection.
BR112012030641A2 (en) methods and compositions for oral pharmaceutical therapy
MX2017004772A (en) Compositions and methods for physiological delivery using cannabidiol.
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
CO6771406A2 (en) A combined composition
CR20210507A (en) Aqueous pharmaceutical composition of an anti-il17a antibody and use thereof
CY1119522T1 (en) (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
RU2013153030A (en) METHOD FOR ADMINISTRATION OF A MEDICINE ON POSTOPERATIVE Wounds WITH DIRECT DENTAL OR JAW PROSTHETICS
TR202010752A2 (en) USE OF BENZIDAMINE HYDROCHLORIDE AND CHITOSAN CONTAINING MEDICAMENT IN ENDODONTIS
CO2023007851A2 (en) Il-7 binding proteins and their use in medical treatments
MX2022001261A (en) Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases.
WO2015102850A3 (en) Compositions, devices and methods for treating infections
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
MA31227B1 (en) PHARMACEUTICAL COMPOSITION COMPRISING PHLOROGLUCINOL AND PARACETAMOL.
CL2022003512A1 (en) Osmotic pharmaceutical forms comprising deutetrabenazine and methods of use thereof
EA200801890A1 (en) MEANS FOR THE TREATMENT OF NOISE IN THE EARS
MX2022001271A (en) Dihydropyrimidine derivatives and uses thereof in the treatment of hbv infection or of hbv-induced diseases.